Groupe Hospitalier Nord Essonne

The medical center is at the forefront of research in the management of severe hyponatremia, focusing on preventing serum sodium overcorrection. This condition poses significant risks, and the center's research aims to enhance patient safety through innovative therapeutic strategies.

• Systematic use of DDAVP
• Prevention of serum sodium overcorrection

By exploring the systematic administration of DDAVP, the center contributes to reducing complications associated with rapid sodium correction, thereby improving clinical outcomes for patients with severe hyponatremia.

Specializing in post-operative care for complicated acute appendicitis, the center evaluates the necessity of antibiotic therapy following laparoscopic appendectomy. This research is pivotal in optimizing treatment protocols and minimizing unnecessary antibiotic use.

• Impact of post-operative antibiotic therapy
• Organ space surgical site infection rates

The center's work in this area aims to refine surgical care practices, ensuring effective treatment while reducing the risk of antibiotic resistance.

Advancing the field of neuro-oncology, the center conducts pioneering research on primary central nervous system lymphoma using PET-MR imaging. This approach enhances the understanding of cerebral distribution and uptake of diagnostic agents.

• [18F]-Fludarabine PET/MR imaging
• Characterization of cerebral distribution

Through this research, the center aims to improve diagnostic accuracy and treatment planning for patients with CNS lymphoma, ultimately leading to better patient outcomes.

The center is a leader in investigating the prevention and treatment of delirium during septic shock. By evaluating the early administration of levetiracetam, the research seeks to enhance patient recovery in intensive care settings.

• Early administration of levetiracetam
• Reduction of coma and delirium days

This research is crucial in developing strategies to improve the quality of life for ICU patients, reducing the duration and impact of delirium during critical illness.

Focusing on acute pyelonephritis in children, the center explores the efficacy of different antibiotic regimens. This research is essential in determining the optimal treatment duration to prevent renal scarring in young patients.

• 3-day intravenous vs. extended oral antibiotic therapy
• Prevention of renal scarring

The center's findings aim to guide pediatric treatment protocols, ensuring effective care while minimizing the risk of long-term kidney damage.